Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter

Pharmacological Reports

Volumn 60, Issue 6, 2008, Pages 1008-1013

  Solich, Joanna ^a   Pałach, Paulina ^a   Budziszewska, Bogusłlawa ^a   Dziedzicka Wasylewska, Marta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

C57BL 6J; Corticosterone; FST; Knock outmice; NET; PCPA; Tianeptine; TST

Indexed keywords

CORTICOSTERONE; FENCLONINE; NORADRENALIN TRANSPORTER; TIANEPTINE; THIAZEPINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DNA MODIFICATION; DRUG EFFICACY; DRUG RESPONSE; EXPERIMENTAL TEST; FEMALE; FORCED SWIMMING TEST; GENOTYPE; IMMOBILIZATION; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; SINGLE DRUG DOSE; TAIL SUSPENSION TEST; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; MOTOR ACTIVITY; PHYSIOLOGY; SWIMMING;

ANIMALS; CORTICOSTERONE; FEMALE; FENCLONINE; HINDLIMB SUSPENSION; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; SWIMMING; THIAZEPINES;

EID: 65249181615     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cryan JF, Mombereau C, Vassout A: The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev, 2005, 29, 571-625.
2. Czeh B, Michaelis T, Watanabe T, Frahm J, de Birrun G, van Kampen M, Bartolomucci A, Fuchs E: Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA, 2001, 98, 12320-12322.
3. Dailly E, Chenu F, Petit-Demouliere B, Bourin M: Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins. J Neurosci Methods, 2006, 150, 111-115.
4. Dziedzicka-Wasylewska M, Faron-Górecka A, Kuśmider M, Drozdowska E, Rogóz Z, Siwanowicz J, Caron MG, Bonisch H: Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology, 2006, 31, 2424-2432.
5. 2 receptors. Behav Brain Res, 2001, 118, 77-83.
6. Haenisch B, Gilsbach R, Bonisch H: Neurotrophin and neuropeptide expression in mouse brain is regulated by knockout of the norepinephrine transporter. J Neural Transm, 2008, 115, 973-982.
7. Jacobson LH, Cryan JF: Feeling strained? Influence of genetic background on depression-related behavior in mice: a review. Behav Genet, 2007, 37, 171-213.
8. Kaminski RM, Shippenberg TS, Witkin JM, Rocha BA: Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures. Neurosci Lett, 2005, 382, 51-55.
9. Kasper S, McEwen BS: Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs, 2008, 22, 15-26.
10. Petit-Demouliere B, Chenu F, Bourin M: Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology, 2005, 177, 245-255.
11. Steru L, Chermat R, Thierry B, Simon P: The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl), 1985, 85, 367-370.
12. Vizi ES, Zsilla G, Caron MG, Kiss JP: Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J Neurosci, 2004, 24, 7888-7894.
13. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG: Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci, 2000, 3, 465-471.